tiprankstipranks
Advertisement
Advertisement

TSE:NRX Stock Latest News

Company AnnouncementsNurExone’s Exo-Top Signs LOI With BioXtek for U.S. Exosome Manufacturing Push
3M ago
NurExone Wins BOLD Healthcare Award and Hires IBN to Boost Investor Visibility
PremiumCompany Announcements
NurExone Wins BOLD Healthcare Award and Hires IBN to Boost Investor Visibility
3M ago
NurExone Bolsters U.S. Exosome Manufacturing With Exo‑Top Sublicense
PremiumCompany Announcements
NurExone Bolsters U.S. Exosome Manufacturing With Exo‑Top Sublicense
3M ago
NRX Upcoming Earnings Report: What to Expect?
PremiumPre-Earnings
NRX Upcoming Earnings Report: What to Expect?
3M ago
NurExone Bolsters European Push and Balance Sheet With Strategic Hire and C$880K Financing
PremiumCompany Announcements
NurExone Bolsters European Push and Balance Sheet With Strategic Hire and C$880K Financing
3M ago
NurExone to Spotlight Exosome Platform at Key 2026 Conferences as Executive Departs
PremiumCompany AnnouncementsNurExone to Spotlight Exosome Platform at Key 2026 Conferences as Executive Departs
4M ago
NurExone Bolsters Exosome Manufacturing Consistency Ahead of Clinical Push
Premium
Company Announcements
NurExone Bolsters Exosome Manufacturing Consistency Ahead of Clinical Push
4M ago
NurExone Adds Healthcare Heavyweight Eyal Gabbai to Board as It Advances Exosome Platform
Premium
Company Announcements
NurExone Adds Healthcare Heavyweight Eyal Gabbai to Board as It Advances Exosome Platform
5M ago
NurExone Exosomes Show Strong Anti-Inflammatory Effect, Outperform Commercial Rival in Lab Tests
PremiumCompany Announcements
NurExone Exosomes Show Strong Anti-Inflammatory Effect, Outperform Commercial Rival in Lab Tests
6M ago
NurExone Advances ExoPTEN Manufacturing for Future Clinical Trials
PremiumCompany Announcements
NurExone Advances ExoPTEN Manufacturing for Future Clinical Trials
6M ago
NurExone Biologic Reports Q3 2025 Results and Key Corporate Milestones
PremiumCompany Announcements
NurExone Biologic Reports Q3 2025 Results and Key Corporate Milestones
7M ago
NRX Earnings this Week: How Will it Perform?
PremiumPre-Earnings
NRX Earnings this Week: How Will it Perform?
7M ago
NurExone Secures C$3.18 Million and Gains Global Recognition for Innovation
PremiumCompany AnnouncementsNurExone Secures C$3.18 Million and Gains Global Recognition for Innovation
7M ago
NurExone Joins ARMI’s BioFab Lab to Boost U.S. Regenerative Manufacturing
Premium
Company Announcements
NurExone Joins ARMI’s BioFab Lab to Boost U.S. Regenerative Manufacturing
8M ago
NurExone to Showcase Exosome Therapy Leadership at Precision EV Forum
Premium
Company Announcements
NurExone to Showcase Exosome Therapy Leadership at Precision EV Forum
8M ago
NurExone’s ExoPTEN Shows Promising Results in Glaucoma Treatment
PremiumCompany Announcements
NurExone’s ExoPTEN Shows Promising Results in Glaucoma Treatment
9M ago
NurExone Biologic to Establish U.S. Manufacturing Facility in Indiana
PremiumCompany Announcements
NurExone Biologic to Establish U.S. Manufacturing Facility in Indiana
9M ago
NurExone Biologic Expands Patent Portfolio and Secures Funding for Growth
PremiumCompany Announcements
NurExone Biologic Expands Patent Portfolio and Secures Funding for Growth
10M ago
NurExone Secures U.S. Patent for Exosome Manufacturing, Bolstering Market Position
PremiumCompany Announcements
NurExone Secures U.S. Patent for Exosome Manufacturing, Bolstering Market Position
10M ago
NurExone Biologic Reports Q2 2025 Financial Results and Strategic Advancements
PremiumCompany AnnouncementsNurExone Biologic Reports Q2 2025 Financial Results and Strategic Advancements
10M ago
NurExone Biologic Reveals Promising Preclinical Results and Closes C$0.78 Million Funding
Premium
Company Announcements
NurExone Biologic Reveals Promising Preclinical Results and Closes C$0.78 Million Funding
10M ago
NurExone’s Exosomes Outperform Industry Standards in Healing Potential
Premium
Company Announcements
NurExone’s Exosomes Outperform Industry Standards in Healing Potential
11M ago

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >